(Q48655154)

13 February 2018

title

Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism. (English)

1 reference

13 February 2018

lysergic acid diethylamide

main subject

1 reference

based on heuristic

inferred from title

author

Lucyna Antkiewicz-Michaluk

series ordinal

1

object named as

Antkiewicz-Michaluk L

1 reference

13 February 2018

3

Vetulani J

1 reference

13 February 2018

author name string

Románska I

series ordinal

2

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

13 February 2018

European Journal of Pharmacology

published in

1 reference

13 February 2018

volume

332

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

9-14

1 reference

13 February 2018

Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Hallucinations: theoretical and clinical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Psychoses precipitated by psychotomimetic drugs. A follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Startle habituation and sensorimotor gating in schizophrenia and related animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Clinical features and management of intoxication due to hallucinogenic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Levodopa-induced psychosis: a kindling phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Measurement of Lysergic Acid Diethylamide (LSD) in Human Plasma by Gas Chromatography/Negative Ion Chemical Ionization Mass Spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Methylenedioxyamphetamine: a selective effect on cortical content and turnover of 5-HT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

LSD. Its rise, fall, and renewed popularity among high school students.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Dopamine receptors and the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901025-X

10.1016/S0014-2999(97)01025-X

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9298920

1 reference

13 February 2018